Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FJZ25
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11.83K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injector units. The contract is unset-aside and competitively awarded on a firm fixed-price basis, with performance originating from the company's Conshohocken, Pennsylvania facility and scheduled completion by October 8, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The current award for SKYRIZI, a specialty injectable pharmaceutical, reflects the company's role in supporting military medical supply chain requirements through its established prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DB25FJZ25?
SPE2DB25FJZ25 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJZ25 worth?
The government has obligated $11,830 on SPE2DB25FJZ25.
Is contract SPE2DB25FJZ25 an order under another contract?
Yes. SPE2DB25FJZ25 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJZ25 competed?
The extent of competition for SPE2DB25FJZ25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award